Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4545845014 | Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4545846010 | Amoxicillin 25 mg/mL and clavulanic acid (as clavulanate potassium) 6.25 mg/mL oral suspension | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
5280071000052116 | amoxicillin 25 mg/ml och klavulansyra (som kaliumklavulanat) 6,25 mg/ml, oral suspension | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has manufactured dose form | Oral suspension | true | Inferred relationship | Some | ||
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Is a | Amoxicillin and clavulanic acid only product in oral dose form | true | Inferred relationship | Some | ||
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Amoxicillin (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 2 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has precise active ingredient | Clavulanate potassium (substance) | true | Inferred relationship | Some | 2 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 2 | |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) | Has basis of strength substance (attribute) | Clavulanic acid (substance) | true | Inferred relationship | Some | 2 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets